A final decision on whether to add these peptides to the 503A list will come later, following the formal rulemaking process
Prep the Vials: Remove the plastic caps from both the Retatrutide vial and the BAC water vial
What the "recipe" involves The formulation described across pharmaceutical references and community forums is straightforward: Sterile water for injection (not distilled water, not purified water sterile water for injection, USP) Benzyl alcohol at 0.9% concentration by volume (9 mg/mL) Combined in a sterile, pyrogen-free container under aseptic conditions The process people describe online typically involves: Sourcing sterile water for injection (sometimes substituted with distilled water a critical error) Calculating the benzyl alcohol volume (0.9 mL per 100 mL of final solution, or 0.27 mL per 30 mL) Combining in a vial or container using a syringe and filter needle Sealing and storing refrigerated On paper, this looks manageable
While oral delivery was tested, its poor bioavailability makes it a poor choice for controlled research
Comprehensive APCs (C-APCs) for CY 2026 (1) Background In the CY 2014 OPPS/ASC final rule with comment period (78 FR 74861 through 74910), we finalized a comprehensive payment policy that packages payment for adjunctive and secondary items, services, and procedures into the most costly primary procedure under the OPPS at the claim level
